A 52-year-old man with type 2 diabetes mellitus and hypertension presents with weakness and palpitations. He has been taking ramipril 5 mg daily and spironolactone 25 mg daily for the past 3 months. Serum potassium is 7.2 mEq/L, creatinine 1.8 mg/dL (baseline 1.2 mg/dL), sodium 138 mEq/L, pH 7.38, HCO₃⁻ 24 mEq/L. ECG shows peaked T waves and widened QRS complex (120 ms). Which of the following is the MOST important predisposing factor in this patient?

Explanation

## Clinical Scenario Analysis This patient has acute symptomatic hyperkalemia (K⁺ 7.2 mEq/L) with ECG changes (peaked T waves, widened QRS) in the setting of: - ACE inhibitor (ramipril) + potassium-sparing diuretic (spironolactone) - Acute rise in creatinine (1.2 → 1.8 mg/dL) suggesting declining renal function - Normal acid-base status (pH 7.38, HCO₃⁻ 24) — acidosis is NOT present - Normal sodium (138 mEq/L) — volume depletion is unlikely ## Pathophysiology of Hyperkalemia in This Context ### The Triple Hit: ACE-I + K⁺-Sparing Diuretic + Declining GFR ```mermaid flowchart TD A[ACE Inhibitor + Spironolactone]:::action --> B[Decreased Angiotensin II]:::outcome B --> C[Reduced Aldosterone Secretion]:::outcome C --> D[Decreased Renal K⁺ Excretion]:::urgent E[Acute Decline in GFR]:::urgent --> F[Reduced Filtered K⁺ Load]:::urgent D --> G[Hyperkalemia K+ 7.2]:::urgent F --> G H[Normal Acid-Base Status]:::outcome --> I[No Shift of K+ Out of Cells]:::outcome I --> J[Hyperkalemia Persists]:::urgent ``` **Key Point:** The most important predisposing factor is the COMBINATION of: 1. **ACE inhibitor** → suppresses angiotensin II → reduces aldosterone 2. **Spironolactone** → directly blocks aldosterone receptor 3. **Acute renal dysfunction** → reduces GFR and filtered K⁺ load Together, these create a "perfect storm" for hyperkalemia. ### Why Acute Renal Decline Is the Trigger | Factor | Role | Evidence in This Case | |--------|------|------------------------| | **ACE-I + Spironolactone** | Chronic suppression of K⁺ excretion | Baseline creatinine 1.2; patient on these drugs for 3 months | | **Acute GFR decline** | Sudden loss of K⁺ filtration capacity | Creatinine rose from 1.2 to 1.8 mg/dL (50% drop in GFR) | | **Timing** | Hyperkalemia develops acutely | Symptoms present NOW, not 3 months ago | **Clinical Pearl:** Patients on ACE-I + K⁺-sparing diuretics often tolerate mild hyperkalemia for months. Acute hyperkalemia with symptoms suggests a **precipitating event** — in this case, acute renal dysfunction (possibly from dehydration, infection, or contrast exposure). ### Why Other Options Are Wrong **Hyperglycemia-induced osmotic diuresis (Option B):** - Osmotic diuresis causes **loss** of K⁺ in urine, leading to hypokalemia, not hyperkalemia - No mention of polyuria, polydipsia, or hyperglycemia in the stem - This would LOWER K⁺, not raise it **Spironolactone-induced aldosterone suppression (Option C):** - True, but this is a CHRONIC effect (patient on it for 3 months) - Does NOT explain the ACUTE presentation NOW - The acute trigger is the decline in renal function **Metabolic acidosis (Option D):** - pH is 7.38 (normal); HCO₃⁻ is 24 (normal) - NO acidosis is present - Acidosis would shift K⁺ OUT of cells (hyperkalemia), but this is not the PRIMARY mechanism here ## High-Yield Summary **High-Yield:** Hyperkalemia in a patient on ACE-I + K⁺-sparing diuretic is usually mild and chronic. **Acute symptomatic hyperkalemia in this setting = acute renal dysfunction until proven otherwise.** Always check for precipitants: dehydration, infection, NSAIDs, contrast exposure, or underlying CKD progression. **Mnemonic: ACE-K** — **ACE inhibitor** + **K⁺-sparing diuretic** + **Declining eGFR** = hyperkalemia. [cite:Harrison 21e Ch 280; KD Tripathi 8e Ch 12]